The Vpr-TET2 axis enhances HIV-1 infection in MDMs by reducing IFITM3 expression via a TET2 dioxygenase-dependent mechanism and by sustaining IL-6 induction via TET2 dioxygenase-independent mechanisms. This evidence concerns the gene IL6 and HIV-1 infection.